Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 11Active not recruiting 4Terminated 3Completed 3Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Sarcoma 3Prostatic Neoplasms 3Stomach Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Thrombosis 1Stroke 1Skin Neoplasms 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Nevus, Pigmented 1Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Liver Neoplasms 1Liposarcoma 1Glioma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Docetaxel 56Prednisone 36enzalutamide 25Leuprolide 24Magnetic Resonance Spectroscopy 19Abiraterone Acetate 19bicalutamide 17Radiotherapy 15Goserelin 15abiraterone 12acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11olaparib 9Androgen Antagonists 9gallium 68 PSMA-11 8cabazitaxel 8Radiotherapy, Intensity-Modulated 8Metformin 8Ketoconazole 8Gonadotropin-Releasing Hormone 8Cyclophosphamide 8apalutamide 7Doxorubicin 7luprolide acetate gel depot 6cabozantinib 6Radiosurgery 6Estramustine 6Dexamethasone 6Calcitriol 6Biopsy 6pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Prostatic Neoplasms × X-Rays × Clear all
NCT02555189 2026-04-22

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Thomas Jefferson University

Phase 1/2 Terminated
52 enrolled 31 charts
Genitourinary

Prostatic Neoplasms

NCT05676463 2026-03-03

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Thomas Jefferson University

Phase 2 Terminated
6 enrolled
Genitourinary

Prostatic Neoplasms

NCT00585741 2012-02-23

Pilot Study of 18F-FLT PET

University of Wisconsin, Madison

Phase NA Terminated
15 enrolled
GastrointestinalGenitourinaryHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡